Drug interactions between antiretrovirals and new or emerging direct-acting antivirals in HIV/hepatitis C virus coinfection.
作者： Drosos E. Karageorgopoulos , Omar El-Sherif , Sanjay Bhagani , Saye H. Khoo
DOI: 10.1097/QCO.0000000000000034
关键词: Virology 、 DIRECT ACTING ANTIVIRALS 、 Anti-Retroviral Agents 、 Healthy individuals 、 Coinfection 、 Human immunodeficiency virus (HIV) 、 Medicine 、 Drug 、 Hepatitis C virus 、 Hcv protease
摘要: Purpose of reviewWe reviewed the pharmacokinetic interactions between direct-acting antivirals against hepatitis C virus (HCV) and antiretroviral agents.Recent findingsMost relevant studies involve healthy individuals refer to already licensed HCV protease inhibitors, bocepre
wkhealth.com参考文章(34)
Varun Garg, Gurudatt Chandorkar, Yijun Yang, Nathalie Adda, Lindsay McNair, Katia Alves, Frances Smith, Rolf P. G. van Heeswijk, The effect of CYP3A inhibitors and inducers on the pharmacokinetics of telaprevir in healthy volunteers. British Journal of Clinical Pharmacology. ,vol. 75, pp. 431- 439 ,(2013) , 10.1111/J.1365-2125.2012.04345.X
Naga Chalasani, Christopher J Gorski, Nilesh H Patel, Stephen D Hall, Raymond E Galinsky, Hepatic and intestinal cytochrome P450 3A activity in cirrhosis: effects of transjugular intrahepatic portosystemic shunts. Hepatology. ,vol. 34, pp. 1103- 1108 ,(2001) , 10.1053/JHEP.2001.29306
Jennifer J. Kiser, James R. Burton, Gregory T. Everson, Drug-drug interactions during antiviral therapy for chronic hepatitis C. Nature Reviews Gastroenterology & Hepatology. ,vol. 10, pp. 596- 606 ,(2013) , 10.1038/NRGASTRO.2013.106
J. González-Moreno, A. Payeras-Cifre, Hepatitis C Virus Infection: Looking for Interferon Free Regimens The Scientific World Journal. ,vol. 2013, pp. 825375- 825375 ,(2013) , 10.1155/2013/825375
Karly P. Garnock-Jones, Boceprevir Drugs. ,vol. 72, pp. 2431- 2456 ,(2012) , 10.2165/11209560-000000000-00000
Francesca J. Torriani, Maribel Rodriguez-Torres, Jürgen K. Rockstroh, Eduardo Lissen, Juan Gonzalez-García, Adriano Lazzarin, Giampiero Carosi, Joseph Sasadeusz, Christine Katlama, Julio Montaner, Hoel Sette, Sharon Passe, Jean De Pamphilis, Frank Duff, Uschi Marion Schrenk, Douglas T. Dieterich, Peginterferon Alfa-2a plus ribavirin for chronic hepatitis C virus infection in HIV-infected patients. The New England Journal of Medicine. ,vol. 351, pp. 438- 450 ,(2004) , 10.1056/NEJMOA040842
J. H. Lewis, J. G. Stine, Review Article: Prescribing Medications in Patients With Cirrhosis - A Practical Guide Alimentary Pharmacology & Therapeutics. ,vol. 37, pp. 1132- 1156 ,(2013) , 10.1111/APT.12324
AU Neumann, MA Polis, L Rozenberg, JO Jackson, KN Reitano, M McLaughlin, C Koratich, RL Dewar, H Masur, BL Haagmans, Shyam Kottilil, Differential antiviral effect of PEG-interferon-α-2b on HIV and HCV in the treatment of HIV/HCV co-infected patients AIDS. ,vol. 21, pp. 1855- 1865 ,(2007) , 10.1097/QAD.0B013E32825EABA7
Caroline Solas, Elodie Pambrun, Maria Winnock, Dominique Salmon, Isabelle Poizot-Martin, Stéphanie Dominguez, Firouzé Bani-Sadr, Jacques Izopet, Rodolphe Garraffo, Gilles Peytavin, Ribavirin and abacavir drug interaction in HIV-HCV coinfected patients: fact or fiction? AIDS. ,vol. 26, pp. 2193- 2199 ,(2012) , 10.1097/QAD.0B013E32835763A4
Varun Garg, Robert S Kauffman, Maria Beaumont, Rolf PG van Heeswijk, Telaprevir: pharmacokinetics and drug interactions. Antiviral Therapy. ,vol. 17, pp. 1211- 1221 ,(2012) , 10.3851/IMP2356